High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers

Fertility and Sterility

Volumn 98, Issue 4, 2012, Pages 1037-1042

  Leader, Benjamin ^a,b   Hegde, Aparna ^c,d   Baca, Quentin ^e   Stone, Kimberly ^a   Lannon, Benjamin ^f   Seifer, David B ^g   Broekmans, Frank ^d   Baker, Valerie L ^b,h  

^a Clinical Research Division   (United States)

^b Rachel's Well   (United States)

^c Center for Minimally Invasive Surgery   (India)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BOSTON IVF   (United States)

^g Genesis Fertility and Reproductive Medicine   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antim llerian hormone; follicle stimulating hormone; ovarian reserve

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; GROUPS BY AGE; HEALTH CENTER; HORMONE BLOOD LEVEL; HUMAN; MENSTRUAL CYCLE; OVARY FUNCTION; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; CHEMISTRY, CLINICAL; ESTRADIOL; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; OOCYTES; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE STANDARDS; REPRODUCTIVE MEDICINE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84866991913     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.06.006     Document Type: Article

References (29)

1. F.J. Broekmans, M.R. Soules, and B.C. Fauser Ovarian aging: mechanisms and clinical consequences Endocr Rev 30 2009 465 493
2. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum müllerian inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil Steril 77 2002 468 471
3. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, and M. Gaudoin Anti-müllerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
4. A. La Marca, S.M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, and L. Roli Anti-müllerian hormone-based prediction model for a live birth in assisted reproduction Reprod Biomed Online 22 2011 341 349
5. R.M. Riggs, E.H. Duran, M.W. Baker, T.D. Kimble, E. Hobeika, and L. Yin Assessment of ovarian reserve with anti-müllerian hormone: a comparison of the predictive value of anti-müllerian hormone, follicle-stimulating hormone, inhibin B, and age Am J Obstet Gynecol 199 2008 202.e1 202.e8
6. C.B. Lambalk, J. van Disseldorp, C.H. de Koning, and F.J. Broekmans Testing ovarian reserve to predict age at menopause Maturitas 63 2009 280 291
7. E.A. Knauff, M.J. Eijkemans, C.B. Lambalk, M.J. ten Kate-Booij, A. Hoek, and C.C. Beerendonk Anti-müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure J Clin Endocrinol Metab 94 2009 786 792
8. S.D. Harlow, M. Gass, J.E. Hall, R. Lobo, P. Maki, and R.W. Rebar Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging Fertil Steril 97 2012 843 845
9. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. Te Velde, and F.J. Broekmans Anti-müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J Clin Endocrinol Metab 91 2006 4057 4063
10. S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, Gervy Ch, and Y. Englert Stable serum levels of anti-müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women Hum Reprod 22 2007 1837 1840
11. A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-müllerian hormone throughout the human menstrual cycle Hum Reprod 21 2006 3103 3107
12. J. van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, B.C. Fauser, and F.J. Broekmans Comparison of inter- and intra-cycle variability of anti-müllerian hormone and antral follicle counts Hum Reprod 25 2010 221 227
13. D.M. Wunder, N.A. Bersinger, M. Yared, R. Kretschmer, and M.H. Birkhäuser Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women Fertil Steril 89 2008 927 933
14. E. Arbo, D.V. Vetori, M.F. Jimenez, F.M. Freitas, N. Lemos, and J.S. Cunha-Filho Serum anti-müllerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills Hum Reprod 22 2007 3192 3196
15. M.H. van den Berg, E. van Dulmen-den Broeder, A. Overbeek, J.W. Twisk, R. Schats, and F.E. van Leeuwen Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases Hum Reprod 25 2010 1520 1527
16. I. Streuli, T. Fraisse, C. Pillet, V. Ibecheole, P. Bischof, and D. de Ziegler Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Fertil Steril 90 2008 395 400
17. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum Reprod Update 12 2006 685 718
18. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
19. S.L. Broer, M. Dólleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum Reprod Update 17 2011 46 54
20. D.B. Seifer, V.L. Baker, and B. Leader Age-specific serum anti-müllerian hormone values for 17,120 women presenting to fertility centers within the United States Fertil Steril 95 2011 747 750
21. R.T. Scott, K.E. Elink-Hirsch, A. Styne-Gross, K.A. Miller, and J.L. Frattarelli The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone Fertil Steril 89 2008 868 878
22. College of American Pathology Surveys 2011 and Anatomic Pathology Education; Y-B Ligand (Special).
23. B. Almog, F. Shehata, S. Suissa, H. Holzer, E. Shalom-Paz, A. La Marca, and S. Muttukrishna Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study Fertil Steril 95 2011 2359 2363
24. N. Gleicher, A. Weghofer, and D.H. Barad Discordances between follicle stimulating hormone (FSH) and anti-müllerian hormone (AMH) in female infertility Reprod Biol Endocrinol 8 2010 64
25. E. Buyuk, D.B. Seifer, J. Younger, R. Grazi, and H. Lieman Random anti-müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels Fertil Steril 95 2011 2369 2372
26. E.S. Sills, M.M. Alper, and A.P.H. Walsh Ovarian reserve screening in infertility: practical applications and theoretical directions for research Eur J Obstet Gynecol Reprod Biol 146 2009 30 36
27. M. Sowers, D. McConnell, K. Gast, H. Zheng, B. Nan, J.D. McCarthy, and J.F. Randolph Anti-müllerian hormone and inhibin B variability during normal menstrual cycles Fertil Steril 94 2010 1482 1486
28. J.F. Dorgan, C.S. Spittle, B.L. Egleston, C.M. Shaw, L.L. Kahle, and L.A. Brinton Assay reproducibility and within-person variation of müllerian inhibiting substance Fertil Steril 94 2010 301 304
29. A. Overbeek, F.J. Broekmans, W.J. Hehenkamp, M.E. Wijdeveld, J. van Disseldorp, and E. van Dulmen-den Broeder Intra-cycle fluctuations of anti-müllerian hormone in normal women with a regular cycle: a re-analysis Reprod Biomed Online 24 2012 664 669